These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23708461)

  • 1. The ubiquitin ligase Siah2 is revealed as an accomplice of the androgen receptor in castration resistant prostate cancer.
    Freeman MR
    Asian J Androl; 2013 Jul; 15(4):447-8. PubMed ID: 23708461
    [No Abstract]   [Full Text] [Related]  

  • 2. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.
    Qi J; Nakayama K; Cardiff RD; Borowsky AD; Kaul K; Williams R; Krajewski S; Mercola D; Carpenter PM; Bowtell D; Ronai ZA
    Cancer Cell; 2010 Jul; 18(1):23-38. PubMed ID: 20609350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.
    Qi J; Pellecchia M; Ronai ZA
    Oncotarget; 2010 Sep; 1(5):379-85. PubMed ID: 21037926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells.
    Fan L; Peng G; Hussain A; Fazli L; Guns E; Gleave M; Qi J
    J Biol Chem; 2015 Aug; 290(34):20865-20879. PubMed ID: 26160177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.
    Qi J; Tripathi M; Mishra R; Sahgal N; Fazli L; Ettinger S; Placzek WJ; Claps G; Chung LW; Bowtell D; Gleave M; Bhowmick N; Ronai ZA
    Cancer Cell; 2013 Mar; 23(3):332-46. PubMed ID: 23518348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.
    Monsef N; Soller M; Panagopoulos I; Abrahamsson PA
    BMC Cancer; 2010 Jul; 10():385. PubMed ID: 20663134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "the E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity." Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA, Signal Transduction Program, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.: Cancer Cell 2013;23(6):332-46.
    Olumi AF
    Urol Oncol; 2014 Feb; 32(2):210-1. PubMed ID: 24445292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
    Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
    Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.
    Monsef N; Helczynski L; Lundwall A; Påhlman S;
    Prostate; 2007 Aug; 67(11):1219-29. PubMed ID: 17562539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic adenocarcinoma with marked neuroendocrine differentiation.
    Islam AM; Kato H; Hayama M; Kobayashi S; Ota H; Nishizawa O
    Int J Urol; 2001 Jul; 8(7):412-5. PubMed ID: 11442667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving concepts in prostatic neuroendocrine manifestations: from focal divergent differentiation to amphicrine carcinoma.
    Bellur S; Van der Kwast T; Mete O
    Hum Pathol; 2019 Mar; 85():313-327. PubMed ID: 30481509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
    Yuan TC; Veeramani S; Lin MF
    Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
    di Sant'Agnese PA
    Urology; 1998 May; 51(5A Suppl):121-4. PubMed ID: 9610566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine differentiation in prostatic malignancy.
    di Sant'Agnese PA; Cockett AT
    Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation].
    Miyoshi Y; Inoue Y; Matsuzaki J; Fukuda M; Satomi Y; Akahane H; Saito S
    Hinyokika Kiyo; 1998 Feb; 44(2):113-6. PubMed ID: 9546133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.
    Jing Y; Nguyen MM; Wang D; Pascal LE; Guo W; Xu Y; Ai J; Deng FM; Masoodi KZ; Yu X; Zhang J; Nelson JB; Xia S; Wang Z
    Oncogene; 2018 Feb; 37(5):638-650. PubMed ID: 28991234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ONECUT2 is a driver of neuroendocrine prostate cancer.
    Guo H; Ci X; Ahmed M; Hua JT; Soares F; Lin D; Puca L; Vosoughi A; Xue H; Li E; Su P; Chen S; Nguyen T; Liang Y; Zhang Y; Xu X; Xu J; Sheahan AV; Ba-Alawi W; Zhang S; Mahamud O; Vellanki RN; Gleave M; Bristow RG; Haibe-Kains B; Poirier JT; Rudin CM; Tsao MS; Wouters BG; Fazli L; Feng FY; Ellis L; van der Kwast T; Berlin A; Koritzinsky M; Boutros PC; Zoubeidi A; Beltran H; Wang Y; He HH
    Nat Commun; 2019 Jan; 10(1):278. PubMed ID: 30655535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine differentiation in prostatic adenocarcinoma does not represent true Paneth cell differentiation.
    di Sant'Agnese PA
    Hum Pathol; 1994 Feb; 25(2):115-6. PubMed ID: 8119711
    [No Abstract]   [Full Text] [Related]  

  • 19. The ubiquitin ligase Siah2 and the hypoxia response.
    Nakayama K; Qi J; Ronai Z
    Mol Cancer Res; 2009 Apr; 7(4):443-51. PubMed ID: 19372575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroendocrine cancers of the prostate].
    Lépinard V; Dauge-Geffroy MC; Delmas V; Bertrand G; Fondimare A; Fetissof F
    Prog Urol; 1993 Feb; 3(1):86-94. PubMed ID: 8485600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.